Cargando…
Evaluation and Management of Hypoactive Sexual Desire Disorder
INTRODUCTION: Hypoactive sexual desire disorder (HSDD) often has a negative impact on the health and quality of life of women; however, many women do not mention—let alone discuss—this issue with their physicians. Providers of gynecologic services have the opportunity to address this subject with th...
Autores principales: | Clayton, Anita H., Kingsberg, Sheryl A., Goldstein, Irwin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5960024/ https://www.ncbi.nlm.nih.gov/pubmed/29523488 http://dx.doi.org/10.1016/j.esxm.2018.01.004 |
Ejemplares similares
-
Effects of Flibanserin on Subdomain Scores of the Female Sexual Function Index in Women With Hypoactive Sexual Desire Disorder
por: Simon, James A., et al.
Publicado: (2022) -
Long-Term Safety and Efficacy of Bremelanotide for Hypoactive Sexual Desire Disorder
por: Simon, James A., et al.
Publicado: (2019) -
Bremelanotide for the Treatment of Hypoactive Sexual Desire Disorder: Two Randomized Phase 3 Trials
por: Kingsberg, Sheryl A., et al.
Publicado: (2019) -
Reliability and validity of the elements of desire questionnaire in premenopausal women with hypoactive sexual desire disorder
por: Revicki, Dennis A., et al.
Publicado: (2020) -
International Society for the Study of Women's Sexual Health Clinical Practice Guideline for the Use of Systemic Testosterone for Hypoactive Sexual Desire Disorder in Women
por: Parish, Sharon J., et al.
Publicado: (2021)